The following three companies, Axcelis Technologies Inc (NASDAQ: ACLS), China Marine Food Group Limited (AMEX: CMFO), and Pluristem Therapeutics Inc (NASDAQ: PSTI) have all made recent, impressive bounce backs…

It’s been my experience that in a bounce back from a dip or a low, there’s always a little normal profit taking along the way, but a day of red ink here and there along the way shouldn’t discourage new investors or aggregators.

Axcelis Technologies for example has had a few down days in its recent bounce back, but the strength of support for the stock reaching a higher valuation has given it a momentum that hasn’t been easy to stop. The stock was trading in the $1.88 range at the beginning of June, dropped to $1.50 by mid June, a loss of 20%, and then bounced back to its current $1.88 range, a gain of 20%. That’s strength of support. Axcelis Technologies has a minimal number of short sellers to hold it down and strong, positive, double digit sales and EPS projections. I think the equipment maker for semiconductor chips can easily retake its late April $2.50 range in the near term.

And on the subject of strong bounce backs, Pluristem Therapeutics, the stem cell company, was trading in the $2.50 range in mid May, and in a long series of little spikes and dips, has fought its way back to its current $3.14 price, a gain of 25.6% in less than eight weeks. Pluristem Therapeutics has virtually no short sellers and there’s a reason for that… For every little dip, a stronger spike has resulted and that indicates there’s some fight in the ‘Faithful’ shareholders of this stock and that it can bring in new buyers.

And China Marine Food Group has also recently proven its shareholders ‘Believe’ as its bounce back from $2.48 in mid June to its current $3.11 price, a gain of 25% in three weeks, affirms. The stock was actually closing in on $3.50 when that profit taking factor I mentioned earlier came into play. But a 25% gain in three weeks show’s some real strength of support and I think it can easily retake $3.25 to $3.30 in the weeks ahead.